|
⚲
|
| Keyboard |
| Adaptimmune Therapeutics PLC
✚
|
|
|---|---|
| CIK # | 0001621227 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001621227] | |
| 10-Q | [0001621227] | |
| 3 | [0001621227] | |
| 4 | [0001621227] | |
| 6-K | [0001621227] | |
| 8-K | [0001621227] | |
| D | [0001621227] | |
| SC 13D | [0001621227] | |
| SC 13G | [0001621227] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
|
2025-08-18 | Sell | 14,671,794 | $0.01 | 146,718 |
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
|
2025-08-15 | Sell | 4,828,206 | $0.01 | 48,282 |
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares
|
2025-07-30 | Sell | 27,433,338 | $0.10 | 2,743,334 |
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares
|
2025-07-29 | Sell | 2,687,460 | $0.10 | 268,746 |
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares
|
2025-07-28 | Sell | 33,931,740 | $0.11 | 3,732,491 |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,074,696 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,612,032 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,612,032 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,612,032 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 5,143,248 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,074,696 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,074,696 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,612,032 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,074,696 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,074,696 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 3,428,832 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2025-02-20 | Grant | 1,612,032 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2025-01-17 | Sell | 5,584 | $0.58 | 3,239 |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2025-01-17 | Sell | 5,584 | $0.58 | 3,239 |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2025-01-17 | Sell | 30,601 | $0.58 | 17,749 |
| showing 20 of 200 most recent transactions | |||||